Dr. Kong is a serial entrepreneur, founder of Precidiag, Inc., and Chairman of the Company’s Scientific and Clinical Advisory Board. His research interests include the impact of gut microbiota on the cause and pathogenesis of disease. He has a particular interest in the study of the gut-brain axis and the influence and method of action of gut microbiota ecosystems on neurological and neurodegenerative disease.